TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Towards Healthcare
U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035

The U.S. CAR T-cell therapies market is expected to grow from USD 3.43 billion in 2026 to USD 42.61 billion by 2035, driven by rising cancer cases, research investments, and innovative therapeutic approaches.

Insights
JNJ   positive

Listed as a key market player in CAR T-cell therapies with potential for significant market expansion